Pharmacological study of the light/dark preference test in zebrafish (Danio rerio): Waterborne administration

Pharmacology Biochemistry and Behavior

Volumn 135, Issue , 2015, Pages 169-176

  Magno, Lílian Danielle Paiva ^a   Fontes, Aldo ^b   Gonçalves, Beatriz Maria Necy ^a   Gouveia, Amauri ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Animal model; Anxiety; Behavior; Drugs; Zebrafish

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; BUSPIRONE; CLONAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; PAROXETINE; RISPERIDONE; WATER;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG SOLUTION; FEMALE; LATENT PERIOD; LIGHT-DARK TEST; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY; WATERBORNE ADMINISTRATION; ZEBRA FISH; ANIMAL; ANXIETY; DARKNESS; DOSE RESPONSE; DRUG EFFECTS; DRUG THERAPY; LIGHT; PSYCHOLOGY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGHT; MOTOR ACTIVITY; WATER; ZEBRAFISH;

EID: 84965120877     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.05.014     Document Type: Article

References (49)

1. Ahmed, O., Seguin, D., Gerlai, R., An automated predator avoidance task in zebrafish. Behav. Brain Res. 216 (2011), 166–171, 10.1016/j.bbr.2010.07.028.
2. Ali, S., Champagne, D.L., Spaink, H.P., Richardson, M.K., Zebrafish embryos and larvae: a new generation of disease models and drug screens. Birth Defects Res. C Embryo Today 93 (2011), 115–133, 10.1002/bdrc.20206.
3. Bagdy, G., Graf, M., Anheuer, Z.E., Modos, E.A., Kantor, S., Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int. J. Neuropsychopharmacol. 4 (2001), 399–408, 10.1017/S1461145701002632.
4. Barbazuk, W.B., Korf, I., Kadavi, C., Heyen, J., Tate, S., Wun, E., Bedell, J.A., McPherson, J.D., Johnson, S.L., The syntenic relationship of the zebrafish and human genomes. Genome Res. 10 (2000), 1351–1358, 10.1101/gr.144700.
5. Barros, T.P., Alderton, W.K., Reynolds, H.M., Roach, A.G., Berghmans, S., Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br. J. Pharmacol. 154 (2008), 1400–1413, 10.1038/bjp.2008.249.
6. Belzung, C., Griebel, G., Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125 (2001), 141–149, 10.1016/S0166-4328(01)00291-1.
7. Bencan, Z., Sledge, D., Levin, E.D., Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol. Biochem. Behav. 94 (2009), 75–80, 10.1016/j.pbb.2009.07.009.
8. Blaser, R.E., Chadwick, L., McGinnis, G.C., Behavioral measures of anxiety in zebrafish (Danio rerio). Behav. Brain Res. 208 (2010), 56–62, 10.1016/j.bbr.2009.11.009.
9. Burghardt, N.S., Bush, D.E.A., McEwen, B.S., LeDoux, J.E., Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist. Biol. Psychiatry 62 (2007), 1111–1118, 10.1016/j.biopsych.2006.11.023.
10. Champagne, D.L., Hoefnagels, C.C.M., de Kloet, R.E., Richardson, M.K., Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav. Brain Res. 214 (2010), 332–342, 10.1016/j.bbr.2010.06.001.
11. Cryan, J.F., Sweeney, F.F., The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br. J. Pharmacol. 164 (2011), 1129–1161, 10.1111/j.1476-5381.2011.01362.x.
12. Dlugos, C.A., Rabin, R.A., Ethanol effects on three strains of zebrafish: model system for genetic investigations. Pharmacol. Biochem. Behav. 74 (2003), 471–480, 10.1016/S0091-3057(02)01026-2.
13. Drapier, D., Bentué-Ferrer, D., Laviolle, B., Millet, B., Allain, H., Bourin, M., Reymann, J.M., Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav. Brain Res. 176 (2007), 202–209, 10.1016/j.bbr.2006.10.002.
14. Egan, R.J., Bergner, C.L., Hart, P.C., Cachat, J.M., Canavello, P.R., Elegante, M.F., Elkhayat, S.I., Bartels, B.K., Tien, A.K., Tien, D.H., Mohnot, S., Beeson, E., Glasgow, E., Amri, H., Zukowska, Z., Kalueff, A.V., Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav. Brain Res. 205 (2009), 38–44, 10.1016/j.bbr.2009.06.022.
15. Enginar, N., Hatipoglu, Ì., Firtina, M., Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats. Pharmacol. Biochem. Behav. 89 (2008), 450–455, 10.1016/j.pbb.2008.02.001.
16. Gebauer, D.L., Pagnussat, N., Piato, Â.L., Schaefer, I.C., Bonan, C.D., Lara, D.R., Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol. Pharmacol. Biochem. Behav. 99 (2011), 480–486, 10.1016/j.pbb.2011.04.021.
17. Gerlai, R., High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 15 (2010), 2609–2622, 10.3390/molecules15042609.
18. Gerlai, R., Zebrafish antipredatory responses: a future for translational research?. Behav. Brain Res. 207 (2010), 223–231, 10.1016/j.bbr.2009.10.008.
19. Giacomini, N.J., Rose, B., Kobayashi, K., Guo, S., Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol. Teratol. 28 (2006), 245–250, 10.1016/j.ntt.2006.01.013.
20. Graeff, F.G., Zangrossi Junior, H., The hypothalamic–pituitary–adrenal axis in anxiety and panic. Psychol. Neurosci. 3 (2010), 3–8, 10.3922/j.psns.2010.1.002.
21. Kim, Y.J., Nam, R.H., Yoo, Y.M., Lee, C.J., Identification and functional evidence of GABAergic neurons in parts of the brain of adult zebrafish (Danio rerio). Neurosci. Lett. 355 (2004), 29–32, 10.1016/j.neulet.2003.10.024.
22. Kurt, M., Arik, A.C., Celik, S., The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test. J. Basic Clin. Physiol. Pharmacol. 11 (2000), 173–180, 10.1515/JBCPP.2000.11.2.173.
23. Maaswinkel, H., Le, X., He, L., Zhu, L., Weng, W., Dissociating the effects of habituation, black walls, buspirone and ethanol on anxiety-like behavioral responses in shoaling zebrafish. A 3D approach to social behavior. Pharmacol. Biochem. Behav. 108 (2013), 16–27, 10.1016/j.pbb.2013.04.009.
24. Margiotta-Casaluci, L., Owen, S.F., Cumming, R.I., de Polo, A., Winter, M.J., Panter, G.H., Rand-Weaver, M., Sumpter, J.P., Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine. PLoS ONE, 9(10), 2014, e110467, 10.1371/journal.pone.0110467.
25. Mathur, P., Guo, S., Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol. Dis. 40 (2010), 66–72, 10.1016/j.nbd.2010.05.016.
26. Mathur, P., Guo, S., Differences of acute versus chronic ethanol exposure on anxiety-like behavioral responses in zebrafish. Behav. Brain Res. 219 (2011), 234–239, 10.1016/j.bbr.2011.01.019.
27. Maximino, C., de Brito, T.M., da Silva Batista, A.W., Herculano, A.M., Morato, S., Gouveia, J., Measuring anxiety in zebrafish: a critical review. Behav. Brain Res. 214 (2010), 157–171, 10.1016/j.bbr.2010.05.031.
28. Maximino, C., de Brito, T.M., de Mattos Dias, C.A.G., Gouveia, A., Morato, S., Scototaxis as anxiety-like behavior in fish. Nat. Protoc. 5 (2010), 209–216, 10.1038/nprot.2009.225.
29. Maximino, C., da Silva, A.W.B., Gouveia, J., Herculano, A.M., Pharmacological analysis of zebrafish (Danio rerio) scototaxis. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 624–631, 10.1016/j.pnpbp.2011.01.006.
30. Rico, E.P., Rosemberg, D.B., Seibt, K.J., Capiotti, K.M., Da Silva, R.S., Bonan, C.D., Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicol. Teratol. 33 (2011), 608–617, 10.1016/j.ntt.2011.07.007.
31. Rihel, J., Schier, A.F., Behavioral screening for neuroactive drugs in zebrafish. Dev. Neurobiol. 72 (2012), 373–385, 10.1002/dneu.20910.
32. Savio, L.E.B., Vuaden, F.C., Piato, A.L., Bonan, C.D., Wyse, A.T., Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish. Prog. Neuropsychopharmacol. Biol. Psychiatry 36 (2012), 258–263, 10.1016/j.pnpbp.2011.10.002.
33. Seibt, K.J., Oliveira, R.L., Zimmermann, F.F., Capiotti, K.M., Bogo, M.R., Ghisleni, G., Bonan, C.D., Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav. Brain Res. 214 (2010), 417–422, 10.1016/j.bbr.2010.06.014.
34. Serra, E.L., Medalha, C.C., Mattioli, R., Natural preference of zebrafish (Danio rerio) for a dark environment. Braz. J. Med. Biol. Res. 32 (1999), 1551–1553, 10.1590/S0100-879X1999001200016.
35. Silva, R.C.B., Brandao, M.L., Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol. Biochem. Behav. 65 (2000), 209–216, 10.1016/S0091-3057(99)00193-8.
36. Silva, M.T.A., Alves, C.R.R., Santarem, E.M.M., Anxiogenic-like effect of acute and chronic fluoxetine on rats tested on the elevated plus-maze. Braz. J. Med. Biol. Res. 32 (1999), 333–339, 10.1590/S0100-879X1999000300014.
37. Steenbergen, P.J., Richardson, M.K., Champagne, D.L., Patterns of avoidance behaviours in the light/dark preference test in young juvenile zebrafish: a pharmacological study. Behav. Brain Res. 222 (2011), 15–25, 10.1016/j.bbr.2011.03.025.
38. Stewart, A., Kadri, F., DiLeo, J., Chung, K.M., Cachat, J., Goodspeed, J., Suciu, C., Roy, S., Gaikwad, S., Wong, K., The developing utility of zebrafish in modeling neurobehavioral disorders. Int. J. Comp. Psychol., 23, 2010.
39. Stewart, A., Wong, K., Cachat, J., Gaikwad, S., Kyzar, E., Wu, N., Hart, P., Piet, V., Utterback, E., Elegante, M., Zebrafish models to study drug abuse-related phenotypes. Rev. Neurosci., 22, 2011, 95, 10.1515/rns.2011.011.
40. Stewart, A., Wu, N., Cachat, J., Hart, P., Gaikwad, S., Wong, K., Utterback, E., Gilder, T., Kyzar, E., Newman, A., Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 1421–1431, 10.1016/j.pnpbp.2010.11.035.
41. Stewart, A., Cachat, J., Suciu, C., Hart, P., Gaikwad, S., Utterback, E., DiLeo, J., Kalueff, A., Intraperitoneal injection as a method of psychotropic drug delivery in adult zebrafish. Kalueff, A.V., Cachat, J.M., (eds.) Zebrafish Neurobehavioral Protocols, 2011, Humana Press, 169–179, 10.1007/978-1-60761-953-6_14.
42. Stewart, A., Maximino, C., de Brito, T.M., Herculano, A.M., Gouveia, A. Jr., Morato, S., Cachat, J.M., Gaikwad, S., Elegante, M.F., Hart, P.C., Neurophenotyping of adult zebrafish using the light/dark box paradigm. Zebrafish Neurobehavioral Protocols, 2011, Springer, 157–167, 10.1007/978-1-60761-953-6_13.
43. Sumanas, S., Lin, S., Zebrafish as a model system for drug target screening and validation. Drug. Discov. Today Targets 3 (2004), 89–96, 10.1016/S1741-8372(04)02428-4.
44. Teixeira, R.C., Zangrossi JR, H., Graeff, F.G., Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 65 (2000), 571–576, 10.1016/S0091-3057(99)00261-0.
45. Varty, G.B., Morgan, C.A., Cohen-Williams, M.E., Coffin, V.L., Carey, G.J., The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology 27 (2002), 357–370, 10.1016/S0893-133X(02)00312-3.
46. Vulink, N.C., Figee, M., Denys, D., Review of atypical antipsychotics in anxiety. Eur. Neuropsychopharmacol. 21 (2011), 429–449, 10.1016/j.euroneuro.2010.12.007.
47. Watanabe, K., Nishimura, Y., Nomoto, T., Umemoto, N., Zhang, Z., Zhang, B., Kuroyanagi, J., Shimada, Y., Shintou, T., Okano, M., Miyazaki, T., Imamura, T., Tanaka, T., In vivo assessment of the permeability of the blood–brain barrier and blood–retinal barrier to fluorescent indoline derivatives in zebrafish. BMC Neurosci., 13, 2012, 101, 10.1186/1471-2202-13-101.
48. Willner, P., Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. 1991, Cambridge University Press.
49. Wong, K., Elegante, M., Bartels, B., Elkhayat, S., Tien, D., Roy, S., Goodspeed, J., Suciu, C., Tan, J., Grimes, C., Chung, A., Rosenberg, M., Gaikwad, S., Denmark, A., Jackson, A., Kadri, F., Chung, K.M., Stewart, A., Gilder, T., Beeson, E., Zapolsky, I., Wu, N., Cachat, J., Kalueff, A.V., Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav. Brain Res. 208 (2010), 450–457, 10.1016/j.bbr.2009.12.023.